These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 20124755)
1. Comparison of corneal wound healing rates after instillation of commercially available latanoprost and travoprost in rat debrided corneal epithelium. Nagai N; Murao T; Okamoto N; Ito Y J Oleo Sci; 2010; 59(3):135-41. PubMed ID: 20124755 [TBL] [Abstract][Full Text] [Related]
2. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Kahook MY; Noecker RJ Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. Khoh-Reiter S; Jessen BA BMC Ophthalmol; 2009 Jul; 9():5. PubMed ID: 19638217 [TBL] [Abstract][Full Text] [Related]
4. Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops. Nagai N; Yoshioka C; Tanino T; Ito Y; Okamoto N; Shimomura Y J Oleo Sci; 2015; 64(7):743-50. PubMed ID: 26136174 [TBL] [Abstract][Full Text] [Related]
5. Enhancing effects of sericin on corneal wound healing in rat debrided corneal epithelium. Nagai N; Murao T; Ito Y; Okamoto N; Sasaki M Biol Pharm Bull; 2009 May; 32(5):933-6. PubMed ID: 19420767 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system. Ryan G; Fain JM; Lovelace C; Gelotte KM BMC Ophthalmol; 2011 Apr; 11():8. PubMed ID: 21510881 [TBL] [Abstract][Full Text] [Related]
7. Decrease in corneal damage due to benzalkonium chloride by the addition of sericin into timolol maleate eye drops. Nagai N; Ito Y; Okamoto N; Shimomura Y J Oleo Sci; 2013; 62(3):159-66. PubMed ID: 23470443 [TBL] [Abstract][Full Text] [Related]
8. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops. Inoue D; Mohamed YH; Uematsu M; Kitaoka T Cutan Ocul Toxicol; 2020 Jun; 39(2):158-164. PubMed ID: 32295438 [No Abstract] [Full Text] [Related]
9. [In vitro evaluation of corneal damages after instillation of eye drops using rat debrided corneal epithelium: changes of corneal damage due to benzalkonium chloride by addition of thickening agents]. Nagai N; Ito Y; Okamoto N; Shimomura Y Yakugaku Zasshi; 2012; 132(7):837-43. PubMed ID: 22790030 [TBL] [Abstract][Full Text] [Related]
10. Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride. Whitson JT; Cavanagh HD; Lakshman N; Petroll WM Adv Ther; 2006; 23(5):663-71. PubMed ID: 17142200 [TBL] [Abstract][Full Text] [Related]
11. [In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)]. Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y Yakugaku Zasshi; 2011; 131(6):985-91. PubMed ID: 21628988 [TBL] [Abstract][Full Text] [Related]
12. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells. Kahook MY; Ammar DA J Ocul Pharmacol Ther; 2010 Jun; 26(3):259-63. PubMed ID: 20565312 [TBL] [Abstract][Full Text] [Related]
13. In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride. McCarey B; Edelhauser H J Ocul Pharmacol Ther; 2007 Oct; 23(5):445-51. PubMed ID: 17941807 [TBL] [Abstract][Full Text] [Related]
14. Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit. Chen W; Dong N; Huang C; Zhang Z; Hu J; Xie H; Pan J; Liu Z PLoS One; 2014; 9(3):e89205. PubMed ID: 24632558 [TBL] [Abstract][Full Text] [Related]
15. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study. Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577 [TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Kahook MY; Noecker R Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744 [TBL] [Abstract][Full Text] [Related]
18. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Ammar DA; Noecker RJ; Kahook MY Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366 [TBL] [Abstract][Full Text] [Related]
19. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo. Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models. Liang H; Baudouin C; Daull P; Garrigue JS; Buggage R; Brignole-Baudouin F Cornea; 2012 Nov; 31(11):1319-29. PubMed ID: 22929154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]